ABO ‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study
Transfusion · 2025
DOI: 10.1111/trf.18338 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transfusion, 2025. Verfasst von Nancy M Dunbar und 27 weiteren Autor:innen. Beteiligte Einrichtung: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA. Hauptthemen laut MEDLINE: ABO Blood-Group System, Platelet Transfusion, Blood Group Incompatibility, Transfusion Reaction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
Alpha‐gal syndrome (AGS) is caused by IgE antibodies against the alpha‐gal oligosaccharide, which is structurally similar to the Group B antigen. Recent case reports of severe allergic transfusion reactions (ATRs) in Group O patients receiving Group B plasma and platelets raise the possibility of a new adverse event, herein called transfusion‐related AGS (TRAGS). The primary goal of this study was to assess the frequency of Groups B and AB plasma and platelet transfusions to Group O patients. Study Design and Methods In this multi‐site retrospective study, participating sites submitted the numbers of platelet and plasma transfusions administered during a 2‐year period categorized by patient and product ABO group.
Results
Fourteen sites from 10 countries participated. Group O patients received Group AB for an average of 9.9% (range 2.8%–29.2%) of plasma transfusions and Group B for 3.2% (0%–12.8%). AB plasma transfusion to Group O patients represented 4.5% (0.9%–14.6%) of the total plasma transfused; Group B 1.4% (0%–5.1%). Group O patients received Group AB for an average of 1.5% (range 0%–5.9%) of platelet transfusions and Group B for 4.1% (0%–14.2%). AB platelet transfusion to Group O patients represented 0.6% (0%–2.7%) of the total platelets transfused; Group B platelets were 1.8% (0%–6.7%).
Discussion
Evidence supporting the possibility of a new adverse event, TRAGS, is accumulating. This study quantifies how often Group O patients may be exposed to Group B antigen in Group B or AB plasma and/or platelet transfusions, providing an estimate of the scope of potential risk for TRAGS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA.
- M-Health Fairview, Minneapolis, Minnesota, USA.
- Western Cape Blood Service, Cape Town, South Africa.
- Etablissement Français du Sang Bourgogne Franche Comté, Besançon, France.
- Welsh Blood Service, Talbot Green, Wales, UK.
- New Zealand Blood Service, Auckland, New Zealand.
ORCID-Profile: Nancy M Dunbar, Richard M Kaufman, Claudia S Cohn, Tomohiko Sato, Richard Schäfer, Silvano Wendel, Alyssa Ziman, Michael F Murphy
Zitieren
APA
Dunbar, N. M., Kaufman, R. M., Bary, K. S., Bellairs, G. R. M., Cohn, C. S., Delettre, F., Ditcham, S., Duarte, G. C., Ellison, A., Fachini, R., George, C. E., Humbrecht, C., Louw, V., Meier, S., Morley, S., Mwase, M., Robitaille, N., Rushford, K., Sato, T., …, & Biomedical Excellence for Safer Transfusion (BEST) Collaborative (2025). ABO ‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study. Transfusion. https://doi.org/10.1111/trf.18338
Vancouver
Dunbar NM, Kaufman RM, Bary KS, Bellairs GRM, Cohn CS, Delettre F, et al. ABO ‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study. Transfusion. 2025. doi:10.1111/trf.18338
BibTeX
@article{Dunbar2025,
author = {Dunbar, Nancy M and Kaufman, Richard M and Bary, Karina S and Bellairs, Gregory R M and Cohn, Claudia S and Delettre, Fanny and Ditcham, Stephanie and Duarte, Gustavo C and Ellison, Amanda and Fachini, Roberta and George, Chloe E and Humbrecht, Catherine and Louw, Vernon and Meier, Sascha and Morley, Sarah and Mwase, Meridah and Robitaille, Nancy and Rushford, Kylie and Sato, Tomohiko and Schäfer, Richard and Staves, Julie and Takanashi, Minoko and Tiberghien, Pierre and Wendel, Silvano and Wood, Erica M and Ziman, Alyssa and Murphy, Michael F and Biomedical Excellence for Safer Transfusion (BEST) Collaborative, Biomedical Excellence for Safer Transfusion (BEST) Collaborative},
title = {ABO ‐mismatched platelet and plasma transfusion practices and the potential for transfusion‐related alpha‐gal syndrome: The Biomedical Excellence for Safer Transfusion Collaborative Study},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18338}
}
EUVIMED